Marcela Maus
Director/Board Member presso 2SEVENTY BIO, INC.
Patrimonio netto: 81 130 $ in data 29/02/2024
Profilo
Founder of Century Therapeutics, Inc., Marcela V.
Maus is on the board of Ichnos Sciences, Inc. and 2seventy Bio, Inc. and Associate Member at Harvard University, Associate Member at Massachusetts Institute of Technology, Director-Cellular Immunotherapy at Massachusetts General Hospital Cancer Center, Associate professor at Harvard Medical School and Associate Member at The Ragon Institute of MGH MIT & Harvard.
She received a doctorate from the University of Pennsylvania and an undergraduate degree from Massachusetts Institute of Technology.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
2SEVENTY BIO, INC.
0.03% | 13/06/2023 | 15 602 ( 0.03% ) | 81 130 $ | 29/02/2024 |
Posizioni attive di Marcela Maus
Società | Posizione | Inizio |
---|---|---|
2SEVENTY BIO, INC. | Director/Board Member | 15/10/2021 |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Director/Board Member | - |
The Ragon Institute of MGH MIT & Harvard | Corporate Officer/Principal | - |
Harvard Medical School | Corporate Officer/Principal | - |
Massachusetts General Hospital Cancer Center
Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Massachusetts Institute of Technology | Corporate Officer/Principal | - |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Precedenti posizioni note di Marcela Maus
Società | Posizione | Fine |
---|---|---|
BLUEBIRD BIO, INC. | Director/Board Member | 04/11/2021 |
CENTURY THERAPEUTICS, INC. | Founder | - |
Formazione di Marcela Maus
University of Pennsylvania | Doctorate Degree |
Massachusetts Institute of Technology | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
BLUEBIRD BIO, INC. | Health Technology |
CENTURY THERAPEUTICS, INC. | Health Technology |
2SEVENTY BIO, INC. | Health Technology |
Aziende private | 3 |
---|---|
Massachusetts General Hospital Cancer Center
Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Health Services |
The Ragon Institute of MGH MIT & Harvard | |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Commercial Services |